AR015768A1 - DERIVADOS DE IMIDAZO PIRIDINA QUE INHIBEN LA SECRECIoN DE ÁCIDO GÁSTRICO, COMPOSICIoN FARMACÉUTICA, PROCEDIMIENTOS PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA, USO DE DICHOS DERIVADOS PARA PREPARAR MEDICAMENTOS Y COMPUESTOS INTERMEDIARIOS uTILES EN EL PROCEDIMIENTO PARA LA PREPARACIoN DE DICHOS DE - Google Patents

DERIVADOS DE IMIDAZO PIRIDINA QUE INHIBEN LA SECRECIoN DE ÁCIDO GÁSTRICO, COMPOSICIoN FARMACÉUTICA, PROCEDIMIENTOS PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA, USO DE DICHOS DERIVADOS PARA PREPARAR MEDICAMENTOS Y COMPUESTOS INTERMEDIARIOS uTILES EN EL PROCEDIMIENTO PARA LA PREPARACIoN DE DICHOS DE

Info

Publication number
AR015768A1
AR015768A1 ARP990101776A ARP990101776A AR015768A1 AR 015768 A1 AR015768 A1 AR 015768A1 AR P990101776 A ARP990101776 A AR P990101776A AR P990101776 A ARP990101776 A AR P990101776A AR 015768 A1 AR015768 A1 AR 015768A1
Authority
AR
Argentina
Prior art keywords
derivatives
alkyl
procedures
preparation
gastric acid
Prior art date
Application number
ARP990101776A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR015768A1 publication Critical patent/AR015768A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Derivados de imidazo piridina que comprenden la formula I o una sal farmacéuticamente aceptable del mismo, donde R1 es (a) H, (b)CH3, o (c)CH2OH; R2 es(a)CH3, (b)CH2CH3, R3 es (a)H, (b)alquilo C1-6, (c)alquilo C1-6 hidroxilado, (d)halogeno, R4 es(a) H, (b)alquilo C1-6, (c)alquilo C1-6hidroxilado, (d)halogeno,R5 es (a)H, (d)halogeno, R6, R7 son iguales o diferentes (a)H, (b)alquilo C1-6, (c)alquilo C1-6 hidroxilado, (d)alquilo C1-6 sustituido con alcoxi C1-6, X es(a)NH, o (b)O. Estoscompuestos i nhiben en forma exogena o endogena la secrecion estimulada de ácido gástrico y pueden usarse por lo tanto para la prevencion ytratamiento de enfermedades inflamatorias intestinales. Procedimientos para su preparacion, formulacionesfarmacéuticas, uso de dichos derivados para prepararmedicamentos y compuestos intermediarios.
ARP990101776A 1998-04-29 1999-04-16 DERIVADOS DE IMIDAZO PIRIDINA QUE INHIBEN LA SECRECIoN DE ÁCIDO GÁSTRICO, COMPOSICIoN FARMACÉUTICA, PROCEDIMIENTOS PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA, USO DE DICHOS DERIVADOS PARA PREPARAR MEDICAMENTOS Y COMPUESTOS INTERMEDIARIOS uTILES EN EL PROCEDIMIENTO PARA LA PREPARACIoN DE DICHOS DE AR015768A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds

Publications (1)

Publication Number Publication Date
AR015768A1 true AR015768A1 (es) 2001-05-16

Family

ID=20411154

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP990101776A AR015768A1 (es) 1998-04-29 1999-04-16 DERIVADOS DE IMIDAZO PIRIDINA QUE INHIBEN LA SECRECIoN DE ÁCIDO GÁSTRICO, COMPOSICIoN FARMACÉUTICA, PROCEDIMIENTOS PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA, USO DE DICHOS DERIVADOS PARA PREPARAR MEDICAMENTOS Y COMPUESTOS INTERMEDIARIOS uTILES EN EL PROCEDIMIENTO PARA LA PREPARACIoN DE DICHOS DE
ARP990101777A AR015769A1 (es) 1998-04-29 1999-04-16 Derivados de imidazo piridina que inhiben la secrecion de acido gastrico, procedimiento para la preparacion de dichos derivados, composicion farmaceutica, uso de dichos derivados para la preparacion de medicamentos, y compuestos intermediarios.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP990101777A AR015769A1 (es) 1998-04-29 1999-04-16 Derivados de imidazo piridina que inhiben la secrecion de acido gastrico, procedimiento para la preparacion de dichos derivados, composicion farmaceutica, uso de dichos derivados para la preparacion de medicamentos, y compuestos intermediarios.

Country Status (34)

Country Link
US (2) US6313136B1 (es)
EP (4) EP1073657B1 (es)
JP (2) JP3883383B2 (es)
KR (3) KR100595806B1 (es)
CN (2) CN1174980C (es)
AR (2) AR015768A1 (es)
AT (4) ATE307130T1 (es)
AU (2) AU769190B2 (es)
BR (2) BR9909995B1 (es)
CA (2) CA2329921A1 (es)
CZ (2) CZ293977B6 (es)
DE (4) DE69927803T2 (es)
DK (2) DK1073656T3 (es)
EE (2) EE04676B1 (es)
ES (2) ES2252975T3 (es)
HK (5) HK1033457A1 (es)
HU (2) HUP0102313A3 (es)
ID (2) ID26819A (es)
IL (4) IL139297A0 (es)
IS (2) IS5683A (es)
MY (2) MY121379A (es)
NO (2) NO318203B1 (es)
NZ (2) NZ507639A (es)
PL (2) PL343797A1 (es)
RU (2) RU2238271C2 (es)
SA (2) SA99200065B1 (es)
SE (1) SE9801526D0 (es)
SI (1) SI1073656T1 (es)
SK (2) SK14912000A3 (es)
TR (4) TR200102728T2 (es)
TW (2) TW490466B (es)
UA (2) UA67769C2 (es)
WO (2) WO1999055706A1 (es)
ZA (2) ZA200005796B (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
EP1368006B1 (en) * 2001-02-13 2006-05-03 AstraZeneca AB Novel modified released formulation
CN1496259A (zh) * 2001-03-08 2004-05-12 新用途
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
DE60317529T2 (de) 2002-09-19 2008-09-25 Schering Corp. Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
WO2004046144A1 (en) 2002-11-19 2004-06-03 Altana Pharma Ag 8-substituted imidazopyridines
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
EP2476667B1 (en) * 2003-02-26 2014-07-16 Sugen, Inc. Aminoheteroaryl compounds as protein kinase inhibitors
SI1606261T1 (sl) 2003-03-10 2010-03-31 Nycomed Gmbh Novi postopek za pripravo roflumilasta
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
SE0303451D0 (sv) 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006064339A1 (en) * 2004-12-17 2006-06-22 Pfizer Japan Inc. Chromane derivatives useful as acid pump antagonists
DK1861074T3 (da) 2005-03-16 2013-07-29 Takeda Gmbh Smagsmaskeret doseringsform indeholdende roflumilast
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
KR101300831B1 (ko) * 2005-03-21 2013-08-30 에스*바이오 피티이 리미티드 이미다조[1,2-ａ]피리딘 유도체, 이의 제조 방법 및 그의약학적 용도
JP2008536817A (ja) * 2005-03-24 2008-09-11 グラクソ グループ リミテッド 胃腸疾患の処置用医薬として有用なイミダゾ（１，２−ａ）ピリジン誘導体
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
US8217057B2 (en) 2005-12-05 2012-07-10 Pfizer Inc. Polymorphs of a c-MET/HGFR inhibitor
KR101026676B1 (ko) * 2005-12-05 2011-04-04 화이자 프로덕츠 인코포레이티드 비정상 세포 성장의 치료 방법
JP2009530262A (ja) * 2006-03-17 2009-08-27 ラクオリア創薬株式会社 クロマン誘導体
JP5571380B2 (ja) 2006-07-24 2014-08-13 ルミナス バイオサイエンシズ，インコーポレイテッド オストワルド熟成を減少させた水不溶性の医薬品物質の固体ナノ粒子処方物
WO2008059373A1 (es) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Vacuna contra la malaria, basada en la subunidad 200l de la proteína msp1 de plasmodium vivax.
EP1974729A1 (en) * 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
US8513226B2 (en) * 2008-03-31 2013-08-20 Council Of Scientific And Industrial Research Simultaneous method for the preparation of a mixture of 3-acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3-acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
CN102470126A (zh) 2009-07-09 2012-05-23 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
CA2913785C (en) * 2013-06-25 2021-08-31 F. Hoffmann-La Roche Ag Compounds for treating spinal muscular atrophy
CA2933811C (en) 2013-12-16 2021-02-09 Asana Biosciences, Llc P2x3 and/or p2x2/3 compounds and methods
ES2692243T3 (es) * 2014-03-24 2018-11-30 Arqule, Inc. Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3H-imidazo[4,5-b]piridin-2-il)piridin-2-amina
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) * 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
US11666888B2 (en) 2018-02-05 2023-06-06 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
BR112020019277B1 (pt) 2018-04-10 2024-01-16 Bayer Aktiengesellschaft Processo para produção de ácidos 2,6-dialquilfenil acéticos, e seus intermediários
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
CA3156073A1 (en) 2019-11-04 2021-05-14 Cinclus Pharma Holding AB Oral formulation of x842
MX2024005463A (es) 2021-11-05 2024-05-22 Cinclus Pharma Holding Ab Publ Polimorfos de la sal de mesilato de glurato de linaprazan.
AU2022381536A1 (en) 2021-11-05 2024-05-02 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법
WO2024149833A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the maleic acid salt of linaprazan glurate
WO2024149834A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrobromide salt of linaprazan glurate
WO2024161317A1 (ko) * 2023-02-01 2024-08-08 제일약품주식회사 약학적 제제, 이의 제조 방법, 및 정제용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound

Also Published As

Publication number Publication date
ES2252975T3 (es) 2006-05-16
CZ293977B6 (cs) 2004-09-15
DE69937077T2 (de) 2008-05-29
MY121379A (en) 2006-01-28
SK285768B6 (sk) 2007-07-06
NZ507639A (en) 2004-01-30
EP1491543A1 (en) 2004-12-29
NO20005450D0 (no) 2000-10-27
EP1073656B1 (en) 2005-10-19
DE69937076D1 (de) 2007-10-18
CA2329922C (en) 2006-04-11
DE69928792T2 (de) 2006-07-20
ES2249913T3 (es) 2006-04-01
ATE307130T1 (de) 2005-11-15
EE200000626A (et) 2002-04-15
EE04916B1 (et) 2007-10-15
EP1073657B1 (en) 2005-12-07
ATE372339T1 (de) 2007-09-15
SE9801526D0 (sv) 1998-04-29
KR20050121760A (ko) 2005-12-27
SA99200065A (ar) 2005-12-03
ATE312101T1 (de) 2005-12-15
WO1999055706A9 (en) 2000-03-16
TR200003176T2 (tr) 2001-03-21
HK1036981A1 (en) 2002-01-25
RU2235725C2 (ru) 2004-09-10
TR200102728T2 (tr) 2002-06-21
IL139200A0 (en) 2001-11-25
CN1174980C (zh) 2004-11-10
CA2329921A1 (en) 1999-11-04
KR100595806B1 (ko) 2006-07-03
EP1491542A3 (en) 2005-01-05
DE69928792D1 (de) 2006-01-12
TW490466B (en) 2002-06-11
KR100595805B1 (ko) 2006-07-03
US6313136B1 (en) 2001-11-06
HUP0102425A2 (hu) 2001-11-28
MY121389A (en) 2006-01-28
PL195000B1 (pl) 2007-07-31
SA99200064B1 (ar) 2006-10-11
JP2002513025A (ja) 2002-05-08
UA66846C2 (uk) 2004-06-15
SA99200065B1 (ar) 2006-11-07
HK1071139A1 (en) 2005-07-08
IS5683A (is) 2000-10-25
AU769190B2 (en) 2004-01-22
NO20005451D0 (no) 2000-10-27
WO1999055705A1 (en) 1999-11-04
NO20005450L (no) 2000-12-22
DE69927803D1 (de) 2006-03-02
HUP0102425A3 (en) 2002-12-28
EE200000664A (et) 2002-04-15
EP1491542B1 (en) 2007-09-05
DE69927803T2 (de) 2006-07-06
DE69937077D1 (de) 2007-10-18
EP1073656A1 (en) 2001-02-07
NO318203B1 (no) 2005-02-14
JP2002513024A (ja) 2002-05-08
JP3883383B2 (ja) 2007-02-21
SK14912000A3 (sk) 2001-06-11
HUP0102313A2 (hu) 2001-12-28
TR200003149T2 (tr) 2001-03-21
KR20010043134A (ko) 2001-05-25
ATE372340T1 (de) 2007-09-15
SI1073656T1 (sl) 2006-02-28
WO1999055706A1 (en) 1999-11-04
NO317262B1 (no) 2004-09-27
CZ20003981A3 (cs) 2001-03-14
US6313137B1 (en) 2001-11-06
AU4300699A (en) 1999-11-16
CZ292567B6 (cs) 2003-10-15
ID27530A (id) 2001-04-12
HK1033457A1 (en) 2001-08-31
ZA200005796B (en) 2002-01-18
NZ507638A (en) 2003-10-31
TWI250159B (en) 2006-03-01
HK1036984A1 (en) 2002-01-25
CN1165535C (zh) 2004-09-08
CZ20003982A3 (cs) 2001-02-14
AR015769A1 (es) 2001-05-16
HUP0102313A3 (en) 2002-10-28
PL343801A1 (en) 2001-09-10
AU769108B2 (en) 2004-01-15
NO20005451L (no) 2000-12-27
ID26819A (id) 2001-02-15
IL139297A0 (en) 2001-11-25
KR20010043133A (ko) 2001-05-25
TR200102612T2 (tr) 2002-06-21
IS5684A (is) 2000-10-25
EE04676B1 (et) 2006-08-15
KR100650472B1 (ko) 2006-11-28
EP1491543B1 (en) 2007-09-05
ZA200005797B (en) 2002-01-18
PL343797A1 (en) 2001-09-10
CN1306533A (zh) 2001-08-01
AU4300799A (en) 1999-11-16
EP1491542A2 (en) 2004-12-29
BR9909996B1 (pt) 2010-08-24
BR9909996A (pt) 2000-12-26
JP3692034B2 (ja) 2005-09-07
HK1033317A1 (en) 2001-08-24
SK14922000A3 (sk) 2001-06-11
IL139200A (en) 2010-04-29
CA2329922A1 (en) 1999-11-04
CN1307577A (zh) 2001-08-08
DK1073657T3 (da) 2006-03-13
IL139297A (en) 2007-06-03
DE69937076T2 (de) 2008-05-29
BR9909995A (pt) 2000-12-26
DK1073656T3 (da) 2006-01-16
UA67769C2 (uk) 2004-07-15
RU2238271C2 (ru) 2004-10-20
EP1073657A1 (en) 2001-02-07
BR9909995B1 (pt) 2010-07-13

Similar Documents

Publication Publication Date Title
AR015768A1 (es) DERIVADOS DE IMIDAZO PIRIDINA QUE INHIBEN LA SECRECIoN DE ÁCIDO GÁSTRICO, COMPOSICIoN FARMACÉUTICA, PROCEDIMIENTOS PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA, USO DE DICHOS DERIVADOS PARA PREPARAR MEDICAMENTOS Y COMPUESTOS INTERMEDIARIOS uTILES EN EL PROCEDIMIENTO PARA LA PREPARACIoN DE DICHOS DE
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
AR011134A1 (es) Derivados de imidazo piridina substituidos para la inhibicion de la secrecion de acido gastrico; una sal del mismo, procedimiento para su preparacion, formulacion farmaceutica que los contiene y el uso de dicho compuesto para la manufactura de un medicamento
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
ATE197050T1 (de) 1-substituierte-4-amino-1h-imidazo 4,5-c chinoline, zwischenprodukte und arzneimittel
ATE152443T1 (de) Anilide-derivate
HUP0203438A2 (hu) Foszfodiészteráz gátló hatású 5-(2-helyettesített-5-heterociklilszulfonilpirid-3-il)-dihidropirazolo[4,3-d]-pirimidin-7-on-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MX9206409A (es) 2-etil 1h-imidazo[4,5-c]quinolin-4-aminas
TR199901006T2 (xx) Heterosiklik t�revler.
AR029190A1 (es) Composiciones que contienen derivados del acido hidroxieicosatetraenoico y uso para la manufactura de un medicamento en el tratamiento de trastornos del ojo seco
PA8485601A1 (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
NZ513096A (en) Compositions for treating inflammatory response
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
BR0108816A (pt) Derivados de quinolina como antagonistas alfa-2
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
FI951858A0 (fi) Kinoloni- ja akridonijohdannaisia virtsanpidätyskyvyttömyyden hoidossa
AR007021A1 (es) Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos
AR007352A1 (es) Derivados sustituidos de bencimidazol, proceso para su preparacion, formulacion farmaceutica que los contiene, y uso de dichos derivados para la manufactura de medicamentos
AR020226A1 (es) Compuestos para la inhibicion de la secrecion de acido gastrico, procesos para su preparacion, formulaciones farmaceuticas y uso de dichos compuestos parapreparar medicamentos
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
PH27446A (en) Compound with gastric acid inhibitory effect
ES2091126T3 (es) Nuevos compuestos biciclicos de pirimidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
EA200400219A1 (ru) Производные хинолина и их использование в качестве противоопухолевых средств

Legal Events

Date Code Title Description
FG Grant, registration